Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

URL of this page:

ZMPSTE24 gene

zinc metallopeptidase STE24

Normal Function

The ZMPSTE24 gene provides instructions for making a protein that acts as a protease, which is an enzyme that cuts (cleaves) other proteins. The ZMPSTE24 protein cuts an immature version of the lamin A protein (prelamin A) at a particular location; this cleavage is an essential step in the maturation of lamin A.

Mature lamin A is a component of the nuclear envelope, which is the membrane that surrounds the nucleus in cells. The nuclear envelope regulates the movement of molecules into and out of the nucleus, and researchers believe it may play a role in regulating the activity of certain genes.

Health Conditions Related to Genetic Changes

Mandibuloacral dysplasia

At least four mutations in the ZMPSTE24 gene cause a form of mandibuloacral dysplasia called mandibuloacral dysplasia with type B lipodystrophy (MADB). This condition is characterized by a variety of signs and symptoms, which can include bone abnormalities, mottled or patchy skin coloring, and loss of fatty tissue under the skin affecting all parts of the body (type B lipodystrophy). ZMPSTE24 gene mutations that cause MADB lead to a reduction of functional ZMPSTE24 protein. As a result, prelamin A is not processed efficiently, and it builds up in cells. In addition, there is a shortage of mature lamin A. Some researchers speculate that these changes damage the nucleus, making cells more fragile. It is not known how the effects of ZMPSTE24 gene mutations relate to the specific signs and symptoms of MADB.

More About This Health Condition

Other disorders

Mutations in the ZMPSTE24 gene that completely eliminate the function of the ZMPSTE24 protein have been identified in newborns with a disorder called lethal restrictive dermopathy. Infants with this disorder have tight, rigid skin; underdeveloped lungs; and other abnormalities. They do not usually survive past the first week of life. Without any functional ZMPSTE24 protein, prelamin A accumulates and mature lamin A is absent; however, it is unclear how these changes lead to the severe signs and symptoms of lethal restrictive dermopathy.

Other Names for This Gene

  • CAAX prenyl protease 1 homolog
  • FACE-1
  • FACE1
  • farnesylated proteins-converting enzyme 1
  • HGPS
  • prenyl protein-specific endoprotease 1
  • PRO1
  • STE24
  • Ste24p
  • zinc metalloproteinase Ste24 homolog

Additional Information & Resources

Tests Listed in the Genetic Testing Registry

Scientific Articles on PubMed

Gene and Variant Databases


  • Ahmad Z, Zackai E, Medne L, Garg A. Early onset mandibuloacral dysplasia due to compound heterozygous mutations in ZMPSTE24. Am J Med Genet A. 2010 Nov;152A(11):2703-10. doi: 10.1002/ajmg.a.33664. Citation on PubMed or Free article on PubMed Central
  • Barrowman J, Michaelis S. ZMPSTE24, an integral membrane zinc metalloprotease with a connection to progeroid disorders. Biol Chem. 2009 Aug;390(8):761-73. doi: 10.1515/BC.2009.080. Citation on PubMed
  • Barrowman J, Wiley PA, Hudon-Miller SE, Hrycyna CA, Michaelis S. Human ZMPSTE24 disease mutations: residual proteolytic activity correlates with disease severity. Hum Mol Genet. 2012 Sep 15;21(18):4084-93. doi: 10.1093/hmg/dds233. Epub 2012 Jun 19. Citation on PubMed or Free article on PubMed Central
  • Ben Yaou R, Navarro C, Quijano-Roy S, Bertrand AT, Massart C, De Sandre-Giovannoli A, Cadinanos J, Mamchaoui K, Butler-Browne G, Estournet B, Richard P, Barois A, Levy N, Bonne G. Type B mandibuloacral dysplasia with congenital myopathy due to homozygous ZMPSTE24 missense mutation. Eur J Hum Genet. 2011 Jun;19(6):647-54. doi: 10.1038/ejhg.2010.256. Epub 2011 Jan 26. Citation on PubMed or Free article on PubMed Central

The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.